Inventor
BACKERT LINUS
DE12 patents
Patents
12 patentsUS12076379B2Sep 3, 2024
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US11872270B2Jan 16, 2024
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US11833193B2Dec 5, 2023
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations73
US11576955B2Feb 14, 2023
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11554164B2Jan 17, 2023
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11246917B2Feb 15, 2022
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US11058755B2Jul 13, 2021
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US10946081B2Mar 16, 2021
*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US10925947B2Feb 23, 2021
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations62
US10869917B2Dec 22, 2020
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations52
US10828357B2Nov 10, 2020
A*03 restricted peptides for use in immunotherapy against cancers and related methods
IMMATICS BIOTECHNOLOGIES GMBH0 citations52
US12480958B2Nov 25, 2025
Method for the characterization of peptide:MHC binding polypeptides
IMMATICS BIOTECHNOLOGIES GMBH0 citations49